by mediaid | Dec 8, 2024 | Lung Cancer Treatment
Alecnib 150 mg, also known as Alectinib, is an advanced ALK (anaplastic lymphoma kinase) inhibitor used for the treatment of ALK-positive non-small cell lung cancer (NSCLC). It has been developed as a highly potent and selective therapy aimed at improving the survival...
by mediaid | Dec 8, 2024 | Lung Cancer Treatment
Osimertinib 80 MG is a revolutionary treatment for patients suffering from EGFR-mutation-positive non-small cell lung cancer (NSCLC). This medication represents an important milestone in the treatment of this particular form of cancer, offering a targeted therapy with...
by mediaid | Sep 29, 2024 | Uncategorized
In the fight against cancer, precision medicines like Lorlanib 100mg play a crucial role in treating specific types of cancers such as anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC). For patients whose disease has progressed...
by mediaid | Sep 29, 2024 | Uncategorized
When facing a diagnosis of Chronic Lymphocytic Leukemia (CLL), understanding your treatment options is essential. One of the medications that have been making strides in managing CLL is Ventoxen 100Mg (Venetoclax). This oral medication targets cancer cells with...
by mediaid | Aug 19, 2024 | Lung Cancer Treatment
Tagrix (Osimertinib) has revolutionized the treatment landscape for Non-Small Cell Lung Cancer (NSCLC), especially in patients harbouring specific genetic mutations. As a third-generation Epidermal Growth Factor Receptor (EGFR) inhibitor, Tagrix targets both the...
